Retail sale of pharmaceutical products
HUNNDALEN APOTEK AS
Revenue 2025
NOK 3.2m
Operating profit
NOK −240,000
Equity
NOK 516,000
Incorporated
2024
Employees
7
Share capital
NOK 800,000
Key figures · 2024
Current ratio
1.24
Equity ratio
9.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -7.5% | |
| Net margin (%%) | -8.7% | |
| Return on assets (%%) | -4.5% | |
| Likviditet | ||
| Current ratio | 1.24 | |
| Working capital | 580k | |
| Soliditet | ||
| Equity ratio (%%) | 9.7% | |
| Debt-to-equity ratio | 9.35 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.